These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 36026578)
21. Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer. Zhao J; Xiao Z; Li T; Chen H; Yuan Y; Wang YA; Hsiao CH; Chow DS; Overwijk WW; Li C ACS Nano; 2018 Oct; 12(10):9881-9893. PubMed ID: 30231203 [TBL] [Abstract][Full Text] [Related]
22. Combination of active targeting, enzyme-triggered release and fluorescent dye into gold nanoclusters for endomicroscopy-guided photothermal/photodynamic therapy to pancreatic ductal adenocarcinoma. Li H; Wang P; Deng Y; Zeng M; Tang Y; Zhu WH; Cheng Y Biomaterials; 2017 Sep; 139():30-38. PubMed ID: 28582716 [TBL] [Abstract][Full Text] [Related]
23. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy. Zhang YF; Jiang SH; Hu LP; Huang PQ; Wang X; Li J; Zhang XL; Nie HZ; Zhang ZG Chin Clin Oncol; 2019 Apr; 8(2):18. PubMed ID: 31070038 [TBL] [Abstract][Full Text] [Related]
24. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts. Liu H; Shi Y; Qian F Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881 [TBL] [Abstract][Full Text] [Related]
26. Terminating the criminal collaboration in pancreatic cancer: Nanoparticle-based synergistic therapy for overcoming fibroblast-induced drug resistance. Wang L; Liu X; Zhou Q; Sui M; Lu Z; Zhou Z; Tang J; Miao Y; Zheng M; Wang W; Shen Y Biomaterials; 2017 Nov; 144():105-118. PubMed ID: 28837958 [TBL] [Abstract][Full Text] [Related]
27. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma. Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874 [TBL] [Abstract][Full Text] [Related]
28. Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2. Sakai S; Iwata C; Tanaka HY; Cabral H; Morishita Y; Miyazono K; Kano MR J Control Release; 2016 May; 230():109-15. PubMed ID: 27080571 [TBL] [Abstract][Full Text] [Related]
29. JS-K Combined with a Melanin-Based Theranostic Agent: A Novel Sequential Delivery Strategy to Enhance the Near-Infrared Fluorescence Imaging of Pancreatic Ductal Adenocarcinoma. Dai M; Qi S; Zhao X; Zhou L; Luo Q; Teng X; Cheng W; Zhou N; Liu H; Chen K Anal Chem; 2024 Mar; 96(10):4103-4110. PubMed ID: 38427614 [TBL] [Abstract][Full Text] [Related]
30. Radiotherapy-Controllable Chemotherapy from Reactive Oxygen Species-Responsive Polymeric Nanoparticles for Effective Local Dual Modality Treatment of Malignant Tumors. Liu TI; Yang YC; Chiang WH; Hung CK; Tsai YC; Chiang CS; Lo CL; Chiu HC Biomacromolecules; 2018 Sep; 19(9):3825-3839. PubMed ID: 30044907 [TBL] [Abstract][Full Text] [Related]
31. Penetrating Micelle for Reversing Immunosuppression and Drug Resistance in Pancreatic Cancer Treatment. Chen Q; Wang Q; Wang Y; Chu Y; Luo Y; You H; Su B; Li C; Guo Q; Sun T; Jiang C Small; 2022 May; 18(18):e2107712. PubMed ID: 35285149 [TBL] [Abstract][Full Text] [Related]
32. Ultrasound-Triggered Piezocatalysis for Selectively Controlled NO Gas and Chemodrug Release to Enhance Drug Penetration in Pancreatic Cancer. Wang Y; Tang Q; Wu R; Sun S; Zhang J; Chen J; Gong M; Chen C; Liang X ACS Nano; 2023 Feb; 17(4):3557-3573. PubMed ID: 36775922 [TBL] [Abstract][Full Text] [Related]
33. Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer. Tao Z; Muzumdar MD; Detappe A; Huang X; Xu ES; Yu Y; Mouhieddine TH; Song H; Jacks T; Ghoroghchian PP Nano Lett; 2018 Apr; 18(4):2195-2208. PubMed ID: 29533667 [TBL] [Abstract][Full Text] [Related]
34. Penetration Cascade of Size Switchable Nanosystem in Desmoplastic Stroma for Improved Pancreatic Cancer Therapy. Zhao X; Yang X; Wang X; Zhao X; Zhang Y; Liu S; Anderson GJ; Kim SJ; Li Y; Nie G ACS Nano; 2021 Sep; 15(9):14149-14161. PubMed ID: 34478262 [TBL] [Abstract][Full Text] [Related]
35. Intratumoral injection of gels containing losartan microspheres and (PLG-g-mPEG)-cisplatin nanoparticles improves drug penetration, retention and anti-tumor activity. Yu M; Zhang C; Tang Z; Tang X; Xu H Cancer Lett; 2019 Feb; 442():396-408. PubMed ID: 30439541 [TBL] [Abstract][Full Text] [Related]
36. Salinomycin-Loaded Small-Molecule Nanoprodrugs Enhance Anticancer Activity in Hepatocellular Carcinoma. Wang J; Zhuo J; Tao Y; Xu S; Chen Z; Yang F; Ke Q; Xie H; Zheng S; Wang H; Xu X Int J Nanomedicine; 2020; 15():6839-6854. PubMed ID: 32982236 [TBL] [Abstract][Full Text] [Related]
37. Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastoma. Iyer R; Croucher JL; Chorny M; Mangino JL; Alferiev IS; Levy RJ; Kolla V; Brodeur GM Cancer Lett; 2015 May; 360(2):205-12. PubMed ID: 25684664 [TBL] [Abstract][Full Text] [Related]
38. Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin. Chen W; Zhou Y; Zhi X; Ma T; Liu H; Chen BW; Zheng X; Xie S; Zhao B; Feng X; Dang X; Liang T Biomaterials; 2019 Feb; 192():590-600. PubMed ID: 30553134 [TBL] [Abstract][Full Text] [Related]
39. Novel SN38 derivative-based liposome as anticancer prodrug: an in vitro and in vivo study. Wu C; Zhang Y; Yang D; Zhang J; Ma J; Cheng D; Chen J; Deng L Int J Nanomedicine; 2019; 14():75-85. PubMed ID: 30587986 [TBL] [Abstract][Full Text] [Related]
40. Hypoxia-activated prodrugs in the treatment of advanced pancreatic adenocarcinoma. Babiker HM; Riaz IB; Shah SR; Von Hoff DD; Borad MJ Anticancer Drugs; 2017 Feb; 28(2):127-132. PubMed ID: 27685167 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]